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1909–2012I am not afraid of death—I am privileged to have been able to work for so
long. If I die tomorrow or in a year, it is the same. It is the message you leave
behind you that counts, and the young scientists who carry on your work.
—Rita Levi-MontalciniRita Levi-MontalciniOn December 30, 2012, Rita Levi-
Montalcini passed away at her home in
Rome at age 103. Rita was a model and
inspiration for the younger generation:
not simply because of her scientific and
political achievements but equally for her
warm personality, exemplary life, and
boundless enthusiasm.
Rita, along with her twin sister Paola,
was born into an intellectual and highly
cultured Turinese Jewish family on April
22, 1909—the two youngest of four chil-
dren.
A polymath, postenlightenment ethos
flowed from their parents to each child,
creating an ambience where intellectual
pursuits were highly appreciated and
avidly pursued. Adamo Levi, her father,
was an engineer and talented mathemati-
cian, and her mother Adele Montalcini,
renowned for her personal charm, was
a gifted painter. Her oldest brother, Gino,
was among Italy’s best-known architects
and a professor at Turin University. Anna
was a keen ‘‘child of the Renaissance’’
immersed in literature and the humanities,
whereas Paola, from early childhood,
displayed extraordinary artistic talents,
especially, like her mother, as a painter.
After completing grammar school,
the young Rita felt unable to adjust to
the conventional feminine role (expected
by her father) and embarked instead on
a career in medical research. As a result,
she studied at Turin University under
Giuseppe Levi, the then Professor of
Histology, who also tutored Salvador
Luria and Renato Dulbecco, two other
future Nobel laureates. All three became
close friends, as well as colleagues.
In 1936, Rita graduated inMedicine and
Surgery and began her specialization in
neuropsychiatry—fortuitously two years
prior to publication of the antisemitic ‘‘A
manifesto for defending our race’’ by
a coterie of Fascist scientists and intellec-tuals (first published on July 15, 1938, it
led to the formulation of Act n. 1024 of
July 13, 1939 XVII, promoted by the
antisemitic area of the National Fascist
Party). Rita spent a short sabbatical in
Brussels in 1940 to improve her neuro-
science skills and returned to Turin
shortly before the German army invaded
Belgium. This was a very difficult time,
and Rita pursued her research activity
from a small laboratory that she built at
home, continuing her collaboration with
Giuseppe Levi until her family was forced
to flee a heavily bombed Turin for
Florence in 1943. During 1943 and 1944,
she established close contacts with parti-
sans through friends and members of the
antifascist coalition known as the Partito
d’Azione (1942–1947, important during
the war as well as in the early postwar
years and leading to the ‘‘AssembleaCell 152Costituente’’ that prepared the new Italian
Constitution). Subsequently, she worked
as a medical doctor assigned to a refugee
camp, where epidemics and infectious
disease daily undermined the health of
already weak and malnourished war
victims.
In opting to specialize in neuropsychi-
atry, Rita was inspired by the Viktor
Hamburger’s early scientific work on the
effects of limb extirpation in chick
embryos. Later, in 1947, Rita was able to
join Hamburger’s laboratory at Washing-
ton University in St. Louis, MO, where in
1956 she became an Associate Professor
and in 1958 became a Full Professor,
a position that she held until her retire-
ment in 1977. During this period, she
also became a member of the Accademia
dei Lincei (Italy’s leading Academic
Society founded in 1603), of the Pontifical
Academy of Sciences (Vatican), of the
Royal Society, and of the National
Academy of Sciences of the USA.
During these years in St Louis, she
collaborated with Stanley Cohen and, in
the early 1950s, found that mouse tumor
cells release a factor that causes rapid
growth of nerve cells both in vitro and
in vivo. Today, it comes as little surprise
that this was nerve growth factor (NGF).
Together with Cohen, Rita shared the
Nobel Prize in Physiology for Medicine
in 1986 for this discovery. NGF as a
neuronal survival factor was identified
well before many other endogenous cell
survival ligands, and consequently, this
discovery became the template for
understanding fundamental mechanisms
in biology.
NGF has the potential to improve
clinical therapy for the increasing burden
of neurodegenerative disease; indeed, it
is now at an advanced stage of optimiza-
tion of formulation and delivery. Rita
contributed significantly to this, partly by
improving large-scale production of re-
combinant human NGF (rhNGF), as well
as through a small-scale human study
that demonstrated how NGF therapy
can reduce retinal-ganglion cell loss in
patients with glaucoma.
In 1962, Rita established a research
unit in Rome, dividing her time between
there and St. Louis. In Rome, she estab-
lished the Institute of Cell Biology at the
Italian National Research Council (CNR).
Additionally, in 2002, to further develop, January 31, 2013 ª2013 Elsevier Inc. 379
basic and applied research on NGF and
neurodegenerative diseases, as well as
to attract world-class scientists, she
created the European Brain Research
Institute (EBRI), also in Rome, where I
had the honor to serve as Scientific
Director. There, I had the great pleasure
of closely interacting with Rita and
admiring her curiosity, her desire to keep
abreast of knowledge, and her ability to
disseminate enthusiasm and persever-
ance among the young scientists—char-
acteristics that persisted to her very
last day. Indeed, her last papers were
published only a few months ago. In
simple words, Rita was a model for
scientists and a model for life. Research
at EBRI covers a wide range of neurode-
generative pathologies, as reflected in
the content of the proceedings published380 Cell 152, January 31, 2013 ª2013 Elsevieon the occasion of her 100th and
102nd birthdays, and I hope the Insti-
tute will continue to diffuse her ideas for
forthcoming generations. The Israel
Hospital in Rome will also shortly adopt
her name.
Beyond medicine, Rita championed
ethics and women’s rights throughout
her adult life. In recent years, the Rita
Levi-Montalcini Foundation has sup-
ported education for thousands of African
women, and Rita herself has published
more than 20 books disseminating her
beliefs as standards for the young. Rita
was among her country’s most popular
women.
In 2001, she was nominated a Senator-
for-Life by Italy’s President Carlo Azeglio
Ciampi and was a firm supporter of the
center-left Romano Prodi government,r Inc.especially during its difficult times. Then,
Rita was determined to be present up to
10 hours in the Chamber, participating in
the discussions and on occasion pro-
viding the crucial single vote of majority.
In the words of Aaron Ciechanover,
‘‘Rita was ‘one of a kind’ in the deepest
and broadest sense of these words, very
close to me in person. Hard to imagine
that this thin, frail, and small Jewish
woman—who was a true lady, the ulti-
mate in fine taste—carved her way during
days when women were hardly seen in
universities, in Fascist Italy, to peaks of
science and humanity, where the air is
thin and only a few, much stronger than
her can survive. She probably had attri-
butes we may never be able to unveil.
I will miss her sorely.’’
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